Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic therapy for urticaria.

C D Kennard1, C N Ellis

  • 1Department of Dermatology, University of Michigan Medical Center, Ann Arbor 48109-0314.

Journal of the American Academy of Dermatology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials.

The Journal of dermatological treatment·2020
Same author

Comparison of three methods for measuring psoriasis severity in clinical studies (Part 2 of 2): use of quality of life to assess construct validity of the Lattice System Physician's Global Assessment, Psoriasis Area and Severity Index and Static Physician's Global Assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

7-5 by '05.

Archives of dermatology·2014
Same author

Assessment of comparative skills between hand-assisted and straight laparoscopic colorectal training on an augmented reality simulator.

Diseases of the colon and rectum·2010
Same author

Ciclosporin in psoriasis clinical practice: an international consensus statement.

The British journal of dermatology·2004
Same journal

Comparative Alopecia Outcomes After Copper and Hormonal Intrauterine Device Placement: A TriNetX Database Retrospective Cohort Study.

Journal of the American Academy of Dermatology·2026
Same journal

Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatologic conditions associated with HIV among US adults across different racial and ethnic groups: A retrospective cohort study using TriNetX.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Considerations in Same-Day Surgical Treatment of a High-Risk, Poorly Differentiated Squamous Cell Carcinoma.

Journal of the American Academy of Dermatology·2026
Same journal

The Ethics of the Handshake in Dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Dermatology images: Hidradenitis suppurativa.

Journal of the American Academy of Dermatology·2026
See all related articles

Treating chronic urticaria is challenging. Newer antihistamines and other medications offer improved results, but understanding the disease is key for effective therapies.

Area of Science:

  • Dermatology
  • Allergology
  • Pharmacology

Background:

  • Chronic urticaria (CU) poses significant challenges for both patients and clinicians.
  • Traditional H1 antagonists, while effective, often cause undesirable side effects.
  • Nonsedating H1 antagonists are increasingly used as alternatives.

Purpose of the Study:

  • To review current and emerging treatment options for chronic urticaria.
  • To highlight the role of different medication classes in managing CU.
  • To emphasize the need for understanding pathogenesis in developing future therapies.

Main Methods:

  • Literature review of pharmacological treatments for chronic urticaria.
  • Analysis of efficacy and side effect profiles of various antihistamines (H1 and H2).

Related Experiment Videos

  • Discussion of adjunctive therapies including antidepressants and mast cell stabilizers.

    • Main Results:

    • Nonsedating H1 antagonists (e.g., terfenadine, astemizole) are replacing older agents due to improved tolerability.
    • Antidepressants and combined H1/H2 antagonist therapy show promise for specific patient subgroups.
    • Mast cell stabilizers and other mediator inhibitors represent potential future treatment avenues.

    Conclusions:

    • Current management of chronic urticaria involves a stepwise approach with evolving pharmacological options.
    • Optimizing treatment requires considering individual patient needs and potential side effects.
    • Further research into the pathogenesis of chronic urticaria is crucial for developing more targeted and effective therapies.